TrialInternational clinical psychopharmacology2014

Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study.

David P McDonnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.